Skip to main content
Equibles

MORGAN STANLEY

Position in GTBP — GT Biopharma, Inc.

CIK 895421 NEW YORK, NY
Back to GTBP Full portfolio

Position in GTBP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,060
+$4,288 QoQ
Shares Held
903
+36.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 57 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. GTBP ranks #422 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in GTBP

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,060 22,573
2026-03-31 $6,772 16,599
2025-12-31 $14,600 18,599
2025-09-30 $8,226 14,015
2025-06-30 $14,373 4,015
2025-03-31 $7,595 3,533
2024-12-31 $10,775 3,533
2024-09-30 $614 266
2024-06-30 $752 266
2024-03-31 $1,178 266
2023-12-31 $2,059 8,078
2023-09-30 $1,946 8,078
2023-06-30 $2,520 8,078
2023-03-31 $4,442 8,078
2022-12-31 $6,920 7,811
2022-09-30 $6,273 3,565
2022-06-30 $400,786 134,043
2022-03-31 $768,710 266,914
2021-12-31 $1,350,518 442,794
2021-09-30 $1,700,438 252,291
2021-06-30 $540,017 34,840
2021-03-31 $17,838 2,608